Amicus Therapeutics, Inc. (OQ:FOLD)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for FOLD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 19/24 Mar 15/24 Campbell Bradley L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -13,375 $11.48
Mar 11/24 Mar 7/24 Sblendorio Glenn Direct Ownership Stock Options (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Mar 11/24 Mar 7/24 Sblendorio Glenn Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $2.80
Mar 6/24 Mar 5/24 Raab Michael Direct Ownership Stock Options (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Mar 6/24 Mar 5/24 Raab Michael Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $2.80
Mar 6/24 Mar 5/24 Mcglynn Margaret G Direct Ownership Stock Options (right to buy) M - Exercise or conversion exempt under rule 16b-3 -7,500  
Mar 6/24 Mar 5/24 Mcglynn Margaret G Direct Ownership Common Stock S - Open market or private sale -7,500 $13.40
Mar 6/24 Mar 5/24 Mcglynn Margaret G Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,500 $2.80
Mar 6/24 Mar 4/24 Mcglynn Margaret G Direct Ownership Stock Options (right to buy) M - Exercise or conversion exempt under rule 16b-3 -7,500  
Mar 6/24 Mar 4/24 Mcglynn Margaret G Direct Ownership Common Stock S - Open market or private sale -7,500 $13.29
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FOLD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 19/24 Mar 15/24 Campbell Bradley L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -13,375 $11.48
Mar 15/24 Jan 9/24 Campbell Bradley L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -23,577 $13.65
Mar 15/24 Jan 9/24 Campbell Bradley L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 28,810  
Mar 15/24 Jan 10/24 Crowley John F Direct Ownership Common Stock S - Open market or private sale -31,614 $13.65
Mar 15/24 Jan 9/24 Crowley John F Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -36,865 $13.65
Mar 15/24 Jan 9/24 Crowley John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 57,620  
Mar 15/24 Jan 9/24 Clark David Michael Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,614 $13.65
Mar 15/24 Jan 9/24 Clark David Michael Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 13,684  
Mar 15/24 Jan 9/24 Castelli Jeff Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,005 $13.65
Mar 15/24 Jan 9/24 Castelli Jeff Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 14,405  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $FOLD

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.